We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Software Platform Extends MS Analysis to Include Small Molecules

By HospiMedica staff writers
Posted on 05 Jun 2008
A new software platform has extended its mass spectrometry (MS) franchise to include small molecules in addition to protein analysis.

Although MS manufacturers are selling an increasing number of instruments for small molecule analysis, the bioinformatics aspect has been mostly underdeveloped. More...
The new software program, SmileMS, offers robust, machine-independent software for the analysis of MS spectra from small molecules; a modern and dynamic user interface enabling users to seamlessly navigate through and share their results; and an open database of small molecule spectra allowing users to add both public and private data, enrich their proper search domain, and more share the database with other users.

SmileMS is a unique software platform for the identification and analysis of small molecules by liquid chromatography-mass spectrometry techniques. Developed by Geneva Bioinformatics (GeneBio; Geneva, Switzerland), in collaboration with the Swiss Institute of Bioinformatics (SIB; Geneva, Switzerland) and Prof. Denis Hochstrasser's group at Geneva University Hospitals (Geneva, Switzerland), SmileMS targets a growing need a growing need for efficient and automatable processes for routine daily analysis of small molecules.

Prof. Denis Hochstrasser said, "My lab has been thoroughly working with the GeneBio team for more than a year now and we are very happy with the quality of the results SmileMS is producing in its early version. The tool by far surpasses other tools we have tested for both the quality of its results, its user-friendliness, and most importantly its extreme flexibility; using the same tool and databases with different separation methods and instruments as well as sharing the results amongst different users through Web access show great promise for routine clinical application.”


Related Links:
Geneva University Hospitals
Geneva Bioinformatics
Swiss Institute of Bioinformatics

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.